Q4 2016 13F Holders as of 31 Dec 2016
-
Type / Class
-
Equity / Common Stock, $0.01 par value per share
-
Shares outstanding
-
209,618,986
-
Number of holders
-
107
-
Total 13F shares, excl. options
-
58,390,925
-
Shares change
-
+1,768,004
-
Total reported value, excl. options
-
$369,592,679
-
Value change
-
+$11,848,602
-
Put/Call ratio
-
33.64%
-
Number of buys
-
51
-
Number of sells
-
-36
-
Price
-
$6.33
Significant Holders of BIOCRYST PHARMACEUTICALS INC - Common Stock, $0.01 par value per share (BCRX) as of Q4 2016
138 filings reported holding BCRX - BIOCRYST PHARMACEUTICALS INC - Common Stock, $0.01 par value per share as of Q4 2016.
BIOCRYST PHARMACEUTICALS INC - Common Stock, $0.01 par value per share (BCRX) has 107 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 58,390,925 shares
of 209,618,986 outstanding shares and own 27.86% of the company stock.
Largest 10 shareholders include BAKER BROS. ADVISORS LP (10,963,944 shares), VHCP Management II, LLC (6,071,142 shares), RTW INVESTMENTS, LP (4,078,895 shares), D. E. Shaw & Co., Inc. (3,683,151 shares), BlackRock Fund Advisors (3,401,744 shares), VANGUARD GROUP INC (3,360,471 shares), DEERFIELD MANAGEMENT CO (3,237,734 shares), RA CAPITAL MANAGEMENT, LLC (2,989,795 shares), STATE STREET CORP (2,092,888 shares), and BlackRock Institutional Trust Company, N.A. (2,079,497 shares).
This table shows the top 107 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.